LXR activation may deprive breast cancer cells of cholesterol by stimulating its efflux through the expression of ABCG1 (ATP-binding cassette sub-family G member 1), a cell carrier of cholesterol. This evidence concerns the gene ABCG1 and breast carcinoma.